Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387308-15-000034
Filing Date
2015-04-14
Accepted
2015-04-14 16:03:30
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10k.htm 10-K 495465
2 EX 31.1 ex311.htm EX-31.1 9822
3 EX 32.1 ex321.htm EX-32.1 5710
4 EX 10.1 george.pdf EX-10.1 6399873
5 EX 10.1 george.htm EX-10.1 470
  Complete submission text file 0001387308-15-000034.txt   10722955

Data Files

Seq Description Document Type Size
6 EX 101.INS axim-20141231.xml EX-101.INS 115692
7 EX 101.SCH axim-20141231.xsd EX-101.SCH 32142
8 EX 101.CAL axim-20141231_cal.xml EX-101.CAL 4731
9 EX 101.DEF axim-20141231_def.xml EX-101.DEF 17143
10 EX 101.LAB axim-20141231_lab.xml EX-101.LAB 148687
11 EX 101.PRE axim-20141231_pre.xml EX-101.PRE 93829
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54296 | Film No.: 15769270
SIC: 4953 Refuse Systems